|
| | Precut n (%) | Biliary stent insertion n (%) | Pancreatic stent insertion n (%) | Biliary sphincterotomy n (%) | Pancreatic sphincterotomy n (%) | Contrast injection into pancreatic duct n (%) | Accidental pass into pancreatic duct n (%) | Endoscopist experience | Prophylactic antibiotics (%) |
|
| Adler (2016) | | 274 (50.9%) | 8 (1.5%) | 87 (16.2%) | | | | Experienced interventional endoscopists | Periprocedural (100%) |
| Alkhatib (2011) | | 70 (38%) | | 76 (41%) | | | | | Intraprocedural (77%)
Postprocedural for 3–7 days (100%) |
| Baluyut (2001) | | 33 (52%) | | Sphincterotomy NOS: 40 (63%) | | | | Pre- and postprocedural (100%) |
| Bangarulingam (2009) | | PSC: 42 (25%)
Non-PSC: 265 (27%) | PSC: 3 (2%)
Non-PSC: 129 (13%) | Sphincterotomy NOS
PSC: 42 (25%)
Non-PSC: 569 (58%) | | | | PSC: Preprocedural (100%)
Non-PSC: N/A |
| Cazzagon (2019) | | | | | | | | | |
| Enns (2003) | | 29 (19.6%) | | | | | | | |
| Etzel (2008) | | PSC: 51 (60.0%)
Non-PSC: 60 (85.7%) | | | | | | | PSC: Preprocedural (98.8%) and postprocedural (89.4%)
Non-PSC: Preprocedural (95.7%) and postprocedural (58.6%) |
| Gluck (2008) | | 43 (51%) | | 64 (60.4%) | | | | | Intraprocedural (100%) |
| Gotthardt (2010) | | 5 (5.2%) | | | | | | Performed by an experienced physician | Periprocedural (100%) |
| Ismail (2012) | 9 (2.0%) | | | 176 (39.9%) | 4 (0.91%) | 15 (3.4%) | 129 (29.3%) | Expert endoscopist | Preprocedural (100%) |
| Kaya (2001) | | Balloon dilation: 0 (0%)
Balloon dilation and stenting: 14 (100%) | | | | | | | Balloon dilation alone: Preprocedural (100%) and postprocedural (64.7%)
Balloon dilation and stenting: Preprocedural (100%) and postprocedural (51.4%) |
| Koskensalo (2020) | Diclofenac: 8 (0.8%)
No diclofenac: 0 (0%) | | Diclofenac: 1 (0.1%)
No diclofenac: 0 (0%) | Diclofenac: 215 (21.5%)
No diclofenac: 409 (40.9%) | | | Diclofenac: 90 (9%)
No diclofenac: 142 (14.2) | | Diclofenac: Preprocedural (100%)
No diclofenac: Preprocedural (100%) |
| Navaneethan (2015) | 19 (2.9%) | 244 (37.1%) | | 31 (10.5%) | 3 (1.0%) | 7 (9.1%) | 32 (4.9%) | Experienced interventional endoscopists | Intraprocedural (100%) |
| Navaneethan (2017) | Group 1 (control): 11 (7.1%)
Group 2 (bile aspiration before contrast injection): 2 (4.4%) | Group 1: 83 (53.2%)
Group 2: 0 (0%) | | Group 1: 4 (2.6%)
Group 2: 11 (23.9%) | Group 1: 4 (2.6%)
Group 2: 2 (4.4%) | Group 1: 27 (17.3%)
Group 2: 5 (10.9%) | Group 1: 15 (9.6%)
Group 2: 2 (4.4%) | Experienced interventional endoscopists with a minimum of 1000 ERCPs prior to the study and an annual average of 400 ERCPs | Group 1: intraprocedural (100%) and postprocedural for 5 days (100%)
Group 2: N/A |
| Parlak (2004) | | 8 (13.8%) | | Sphincterotomy NOS: 37 (100%) | | | | |
| Peiseler (2018) | | 69 (10.4%) | | 116 (17%) | | | | Experienced endoscopist | Intraprocedural and postprocedural for 2 days (96%) |
| Ponsioen (2018) | | 34 (52.3%) | | 24 (36.9) | | | | | |
| Rupp (2019) | | | | Sphincterotomy NOS: 286 (100%) | | | Experienced endoscopists | Prophylactic antibiotics (100%) |
| Thiruvengadam (2016) | | | | | | | | Endoscopists ranged in experience | |
| Von Seth (2015) | PSC: 15 (11%)
Non-PSC: 756 (9%) | PSC: 38 (27%)
Non-PSC: 3226 (37%) | PSC: 2 (1.4%)
Non-PSC: 63 (0.6%) | Sphincterotomy NOS:
PSC: 50 (35%)
Non-PSC: 5554 (63%) | | PSC: 44 (31%)
Non-PSC: 2472 (28%) | | PSC: prophylactic (49%)
Non-PSC: prophylactic (36%) |
|
